Home > News > AlphaRx Completes Formulation Development of Vansolin(TM)
September 20th, 2005
AlphaRx Completes Formulation Development of Vansolin(TM)
Abstract:
AlphaRx Inc. today announced that it has completed the formulation development of a novel antibiotic formulation using its patent pending solid lipid nanoparticle delivery platform. According to published research papers, in vitro the uptake of Vancomycin nanoparticles by white blood cells is 20 times more than free drug.
Source:
arrivenet.com
Bookmark:
| Related News Press |
Nanomedicine
Multiphoton polymerization: A promising technology for precision medicine February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
SMART researchers pioneer first-of-its-kind nanosensor for real-time iron detection in plants February 28th, 2025
Materials/Metamaterials/Magnetoresistance
Chainmail-like material could be the future of armor: First 2D mechanically interlocked polymer exhibits exceptional flexibility and strength January 17th, 2025
Enhancing transverse thermoelectric conversion performance in magnetic materials with tilted structural design: A new approach to developing practical thermoelectric technologies December 13th, 2024
FSU researchers develop new methods to generate and improve magnetism of 2D materials December 13th, 2024
Announcements
Closing the gaps — MXene-coating filters can enhance performance and reusability February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||